Page 90 - 22-0424

The International Journal of the Royal Society of Thailand
Volume XI - 2019

Conclusion

The development of next-generation sequencing has greatly enriched our
knowledge of the precise genetic alterations of human diseases during the past
decade. Precise molecular diagnosis will enable targeted therapies and better

management. Efforts are underway to incorporate patient phenotype and genotype
data to develop databased predictors of treatment response as well as potential
novel therapeutics. Genome editing and induced pluripotent stem cell technologies
could accelerate the path to precision medicine. Advances in genomics and
precision health are creating new opportunities for evidence-based and patient-
centered care achieving the goal of improving clinical outcomes and promoting
patients’ quality of life.

References

Amarinthnukrowh P, Tongkobpetch S, Kongpatanayothin A, Suphapeetiporn K,
Shotelersuk V. p.D645E of acid α-glucosidase is the most common mutation
in thai patients with infantile-onset pompe disease. Genet Test Mol
Biomarkers. 2010;14(6):835–837. doi:10.1089/gtmb.2010.0038.

Boonsimma P, Michael GM, Netbaramee W, Wechapinan T, Srichomthong C,
Ittiwut C, et al. Mutational and phenotypic expansion of ATP1A3-related
disorders: Report of nine cases. Gene. 2020;749:144709. doi:10.1016/j.gene.
2020.144709.

Boonsimma P, Suwannachote S, Phokaew C, Ittiwut C, Suphapeetiporn, K
Shotelersuk V. A case of GABRA5-related developmental and epileptic
encephalopathy with response to a combination of antiepileptic drugs and
a GABAering agent. Brain Dev. 2020;42(7):546–550. doi:10.1016/j.braindev.
2020.03.005.

Choi SM, Kim Y, Shim JS, Park JT, Wang RH, Leach SD, et al. Efficient drug
screening and gene correction for treating liver disease using patient-
specific stem cells. Hepatology. 2013;57(6):2458–68. doi:10.1002/hep.26237.

Chongsrisawat V, Damrongphol P, Ittiwut C, Ittiwut R, Suphapeetiporn K,
Shotelersuk V. The phenotypic and mutational spectrum of Thai female
patients with ornithine transcarbamylase deficiency. Gene. 2018;679:377–381.
doi:10.1016/j.gene.2018.09.026.

84 Precision Medicine in Hereditary Neurological Disorders:
From Diagnosis to Treatment

11/7/2565 BE 13:30
_22-0424(077-088)8.indd 84
_22-0424(077-088)8.indd 84 11/7/2565 BE 13:30